Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The objective of this study is to evaluate the safety, tolerability, and efficacy of BL-M07D1 in patients with HER2 expressing advanced tumors.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pełnoletni pacjenci (18 lat i więcej)
- •Oczekiwana długość życia co najmniej 3 miesiące
- •Potwierdzony zaawansowany nowotwór z ekspresją HER2 (nieoperacyjny lub oporny na dotychczasowe leczenie)
- •Wcześniejsze otrzymanie co najmniej 2 linii standardowego leczenia
- •Chęć uczestnictwa i podpisanie świadomej zgody
- •Dostępne próbki tkanki nowotworu do badania HER2
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 20, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (17)
University of Alabama Birmingham
Birmingham, United States
City of Hope
Duarte, United States
Cedars Sinai
Los Angeles, United States
Scripps Health
San Diego, United States
University of Miami
Miami, United States
Sarah Cannon Research institute - Lake Nona Florida
Orlando, United States
Georgia Cancer Center at Augusta University
Augusta, United States
University of Illinois Cancer Center
Chicago, United States
University of Chicago Medicine
Chicago, United States
Dana Farber Cancer Institute
Boston, United States
Karmanos Cancer Institiute
Detroit, United States
NYU Langone Hospital - Long Island Investigational Pharmacy
Mineola, United States
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health
New York, United States
Providence Portland Medical Center
Portland, United States
Sarah Cannon Research Institute
Nashville, United States
Oncology Consultants
Houston, United States
Virginia Cancer Specialists
Fairfax, United States
Trial contact
Christine LaRock
Whitney Eakins
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/21/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.